Sam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT reports.
© 2024 TechCrunch. All rights reserved. For personal use only.
from TechCrunch https://ift.tt/taDMAjmSam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT reports.
© 2024 TechCrunch. All rights reserved. For personal use only.
from TechCrunch https://ift.tt/taDMAjmThe former OpenAI researcher’s fund was forced to unwind public equities after leveraged public bets plummeted. But he still has cards to pl...
No comments:
Post a Comment